Return On Assets in % of Eiger BioPharmaceuticals, Inc. from Q3 2014 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Return On Assets history and change rate from Q3 2014 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Return On Assets for the quarter ending 31 Dec 2023 was -113 %, a 69.1% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2023 was -113 %, a 69.1% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2022 was -66.6 %, a 194% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2021 was -22.7 %, a 58.6% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2023 -113 -46.1 -69.1% 01 Oct 2023 31 Dec 2023
Q3 2023 -99.8 -36.1 -56.8% 01 Jul 2023 30 Sep 2023
Q2 2023 -87.9 -27.3 -45% 01 Apr 2023 30 Jun 2023
Q1 2023 -73.6 -14.1 -23.7% 01 Jan 2023 31 Mar 2023
Q4 2022 -66.6 -44 -194% 01 Oct 2022 31 Dec 2022
Q3 2022 -63.6 -43.5 -217% 01 Jul 2022 30 Sep 2022
Q2 2022 -60.7 -44.8 -283% 01 Apr 2022 30 Jun 2022
Q1 2022 -59.5 -44.9 -307% 01 Jan 2022 31 Mar 2022
Q4 2021 -22.7 +32 +58.6% 01 Oct 2021 31 Dec 2021
Q3 2021 -20.1 +37.7 +65.2% 01 Jul 2021 30 Sep 2021
Q2 2021 -15.8 +47.6 +75% 01 Apr 2021 30 Jun 2021
Q1 2021 -14.6 +46.6 +76.1% 01 Jan 2021 31 Mar 2021
Q4 2020 -54.7 +7.6 +12.2% 01 Oct 2020 31 Dec 2020
Q3 2020 -57.8 +4.52 +7.26% 01 Jul 2020 30 Sep 2020
Q2 2020 -63.5 +5.63 +8.15% 01 Apr 2020 30 Jun 2020
Q1 2020 -61.2 +10.6 +14.8% 01 Jan 2020 31 Mar 2020
Q4 2019 -62.3 +12.7 +17% 01 Oct 2019 31 Dec 2019
Q3 2019 -62.3 +22.9 +26.8% 01 Jul 2019 30 Sep 2019
Q2 2019 -69.1 +14.5 +17.4% 01 Apr 2019 30 Jun 2019
Q1 2019 -71.8 +33.6 +31.9% 01 Jan 2019 31 Mar 2019
Q4 2018 -75 +26.4 +26.1% 01 Oct 2018 31 Dec 2018
Q3 2018 -85.1 +10.6 +11.1% 01 Jul 2018 30 Sep 2018
Q2 2018 -83.6 +5.29 +5.95% 01 Apr 2018 30 Jun 2018
Q1 2018 -105 -15 -16.5% 01 Jan 2018 31 Mar 2018
Q4 2017 -101 -18.4 -22.1% 01 Oct 2017 31 Dec 2017
Q3 2017 -95.7 -40 -71.7% 01 Jul 2017 30 Sep 2017
Q2 2017 -88.9 -39.2 -78.8% 01 Apr 2017 30 Jun 2017
Q1 2017 -90.5 -36.7 -68.3% 01 Jan 2017 31 Mar 2017
Q4 2016 -83 -52.9 -176% 01 Oct 2016 31 Dec 2016
Q3 2016 -55.7 -49.4 -779% 01 Jul 2016 30 Sep 2016
Q2 2016 -49.7 -41.6 -512% 01 Apr 2016 30 Jun 2016
Q1 2016 -53.8 -62.4 -720% 01 Jan 2016 31 Mar 2016
Q4 2015 -30.1 -27.2 -936% 01 Oct 2015 31 Dec 2015
Q3 2015 -6.34 +10.5 +62.4% 01 Jul 2015 30 Sep 2015
Q2 2015 -8.13 01 Apr 2015 30 Jun 2015
Q1 2015 8.68 01 Jan 2015 31 Mar 2015
Q4 2014 -2.91 01 Oct 2014 31 Dec 2014
Q3 2014 -16.9 01 Jul 2014 30 Sep 2014

Eiger BioPharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -113 -46.1 -69.1% 01 Jan 2023 31 Dec 2023
2022 -66.6 -44 -194% 01 Jan 2022 31 Dec 2022
2021 -22.7 +32 +58.6% 01 Jan 2021 31 Dec 2021
2020 -54.7 +7.6 +12.2% 01 Jan 2020 31 Dec 2020
2019 -62.3 +12.7 +17% 01 Jan 2019 31 Dec 2019
2018 -75 +26.4 +26.1% 01 Jan 2018 31 Dec 2018
2017 -101 -18.4 -22.1% 01 Jan 2017 31 Dec 2017
2016 -83 -52.9 -176% 01 Jan 2016 31 Dec 2016
2015 -30.1 -27.2 -936% 01 Jan 2015 31 Dec 2015
2014 -2.91 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.